Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

ClinicalTrials.gov ID: NCT04423718

Public ClinicalTrials.gov record NCT04423718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In this study researchers want to learn more about changes in visual acuity (clarity of vision) with a high dose treatment with Aflibercept (Eylea) in patients suffering from neovascular age-related macular degeneration (nAMD). Neovascular AMD is an eye disease that causes blurred vision or a blind spot due to abnormal blood vessels that leak fluid or blood into the light sensitive lining inside the eye (retina). The fluid buildup causes the central part of the retina (macula) responsible for sharp, straight-ahead vision to swell and thicken (edema), which distorts vision.

Study identification

NCT ID
NCT04423718
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
1,011 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2020 (Actual)
Primary completion
Jul 27, 2022 (Actual)
Completion
Aug 7, 2024 (Actual)
Last update posted
Aug 29, 2025

2020 – 2024

United States locations

U.S. sites
57
U.S. states
27
U.S. cities
55
Facility City State ZIP Site status
Arizona Retina & Vitreous Consultants - Central Phoenix Phoenix Phoenix Arizona 85021-8865 —
Retina Consultants of Orange County - Fullerton Fullerton California 92835 —
Northern California Retina Vitreous Associates - Mountain View Office Mountain View California 94040 —
Azul Vision Pasadena Pasadena California 91107 —
Retina Consultants San Diego - Poway Poway California 92064 —
Retina Consultants of Southern California Redlands California 92374 —
Kaiser Permanente Riverside Medical Center - Cardiology Riverside California 92505 —
Perlman Medical Offices at UC San Diego Health - Endocrinology San Diego California 92037 —
Retina Consultants of Southern Colorado, PC Colorado Springs Colorado 80909 —
New England Retina Associates New London Connecticut 06320 —
Rand Eye Institute Deerfield Beach Florida 33064 —
Retina Group of Florida - Fort Lauderdale Fort Lauderdale Florida 33308 —
Vitreo Retinal Associates PA - The Millennium Center Location Gainesville Florida 32607-2557 —
Florida Retina Institute- Jacksonville Oak Jacksonville Florida 32204 —
Florida Eye Associates - Melbourne Main Office Melbourne Florida 32901 —
Retina Macula Specialists Of Miami - LeJeune Road Office Miami Florida 33126 —
Florida Retina Institute - Orlando Orlando Florida 32806 —
Retina Specialty Institute - Pensacola Pensacola Florida 32503 —
Retina Vitreous Associates of Florida - Saint Petersburg St. Petersburg Florida 33711 —
Southern Vitreoretinal Associates, P.L. - Tallahassee Tallahassee Florida 32308 —
Retina Consultants of Hawaii - Pali Momi Medical Center ‘Aiea Hawaii 96701 —
Retina Associates IL Elmhurst Illinois 60126 —
University Retina and Macula Associates Oak Forest Illinois 60452 —
Wolfe Eye Clinic - Des Moines West Des Moines Iowa 50266-7705 —
The Retina Care Center - Baltimore Baltimore Maryland 21209 —
Ophthalmic Consultants of Boston - Boston Boston Massachusetts 02114 —
Vitreo Retinal Surgery PA - Edina Edina Minnesota 55435 —
Retina Consultants of Nevada - Summerlin Las Vegas Nevada 89144 —
Retina Center of New Jersey Bloomfield New Jersey 07003 —
NJ Retina - Edison Office Edison New Jersey 08820 —
Eye Associates of New Mexico - Albuquerque - Retina Center Albuquerque New Mexico 87109 —
Long Island Vitreoretinal Consultants - Great Neck Great Neck New York 11021 —
Vitreoretinal Consultants of NY - Hauppauge Hauppauge New York 11788 —
Ophthalmic Consultants of Long Island Lynbrook New York 11563 —
Ophthalmic Consultants of the Capital Region - Troy Troy New York 12180 —
Wake Forest Baptist Health Winston-Salem North Carolina 27157 —
Midwest Retina - Main Office Dublin Ohio 43016 —
Retina Northwest - NW Lovejoy Portland Oregon 97210 —
Retina Consultants, LLC Salem Oregon 97302 —
Mid Atlantic Retina - Philadelphia / Wills Eye Hospital Bethlehem Pennsylvania 18017 —
Erie Retinal Research Erie Pennsylvania 16507 —
Eye Care Specialists - Kingston, PA Kingston Pennsylvania 18704 —
Charleston Neuroscience Institute - Charleston Charleston South Carolina 29414 —
Palmetto Retina Center - West Columbia West Columbia South Carolina 29169 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Charles Retina Specialists - Germantown Memphis Tennessee 38119 —
Vanderbilt University Medical School Nashville Tennessee 37212-1610 —
Austin Retina Associates - Central Austin Texas 78705 —
Texas Retina Associates - Fort Worth Fort Worth Texas 76104 —
Medical Center Ophthalmology Associates - Northwest San Antonio Texas 78240 —
Retina Consultants of Texas - San Antonio Medical Center San Antonio Texas 78240 —
Retina Consultants of Texas (Retina Consultants of Houston) - Texas Medical Center The Woodlands Texas 77384 —
Retina Consultants of Texas - The Woodlands The Woodlands Texas 77384 —
The University of Vermont Medical Center (Fletcher Allen Health Care) - Main Campus Burlington Vermont 05401-1473 —
Spokane Eye Clinical Research Spokane Washington 99204 —
West Virginia University Morgantown West Virginia 26505 —
University of Wisconsin - Madison Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 178 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04423718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 29, 2025 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04423718 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →